Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03482505 · ClinicalTrials.gov registry record · NA

Rainbow Acoustic Monitoring (RAM) in Patients Weighing up to 10kg Comparison Study

A NA study, sponsored by Masimo Corporation.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT03482505: Clinical Trial NA study, sponsored by Masimo Corporation.

NCT03482505 is a NA study that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03482505, a NA study, was terminated before completion, sponsored by Masimo Corporation.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The objective of this clinical investigational study is to compare the acoustic respiration rates (RRa) obtained using the INVSENSOR0004 sensor in the subjects up to 10 kg with the respiration rates determined by manual annotations (RRref), and when applicable with capnography respiration rate (RRcap).

Primary Outcome

Acoustic respiration rate (RRa) as determined by the INVSENSOR00004 will be compared to measurements of actual respiration rates as determined by manual annotation of recorded respiration waveform (RRref) data. Evaluation of the RRa measurements will be reported as bias between the RRa and the RRref.

Interventions

  • DEVICE INVSENSOR00004

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2018-03-12
Est. Completion 2018-08-31
Phase NA
Masimo Corporation

96 total trials

Why NCT03482505 stopped before completion

NCT03482505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00004 is the first listed.

NCT03482505 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03482505 about?

NCT03482505 is a clinical study titled "Rainbow Acoustic Monitoring (RAM) in Patients Weighing up to 10kg Comparison Study". The objective of this clinical investigational study is to compare the acoustic respiration rates (RRa) obtained using the INVSENSOR0004 sensor in the subjects up to 10 kg with the respiration rates determined by manual annotations (RRref), and when applicable with capnography respiration rate (RRca...

What is the current status of trial NCT03482505?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-03-12. Estimated completion is 2018-08-31.

What interventions are being tested in trial NCT03482505?

The interventions under investigation include: INVSENSOR00004 (DEVICE).

Who is sponsoring clinical trial NCT03482505?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03482505's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03482505, the US trial registry maintained by the National Library of Medicine. NCT03482505 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.